Inflammatory molecule expression in cerebral arteriovenous malformations

Journal of Clinical Neuroscience

Volumn 15, Issue 2, 2008, Pages 179-184

  Storer, Kingsley P ^a   Tu, Jian ^a   Karunanayaka, Athula ^a   Morgan, Michael K ^b   Stoodley, Marcus A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Arteriovenous malformation; E selectin; ICAM 1; P selectin; VCAM 1

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ARTERIOVENOUS MALFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PATHOPHYSIOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSURGERY; SCHOOL CHILD; UPREGULATION; VASCULAR ENDOTHELIUM;

ADULT; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MIDDLE AGED; VON WILLEBRAND FACTOR;

EID: 37349064815     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.10.013     Document Type: Article

References (16)

1. Shenkar R., Elliott J.P., Diener K., et al. Differential gene expression in human cerebrovascular malformations. Neurosurgery 52 (2003) 465-477 discussion 477-8
2. Rothbart D., Awad I.A., Lee J., et al. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38 (1996) 915-924 discussion 924-5
3. Koizumi T., Shiraishi T., Hagihara N., et al. Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 50 (2002) 117-126
4. Hashimoto T., Emala C.W., Joshi S., et al. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47 (2000) 910-919
5. Hatva E., Jaaskelainen J., Hirvonen H., et al. Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. Journal of Neuropathology and Experimental Neurology 55 (1996) 1124-1133
6. Tu J., Stoodley M.A., Morgan M.K., et al. Responses of arteriovenous malformations to radiosurgery: ultrastructural changes. Neurosurgery 58 (2006) 749-758
7. Uranishi R., Awadallah N.A., Ogunshola O.O., et al. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery 50 (2002) 110-116
8. Kilic T., Pamir M.N., Kullu S., et al. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46 (2000) 1179-1192
9. Hashimoto T., Lawton M.T., Wen G., et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54 (2004) 410-423 discussion 423-5
10. Frijns C.J., and Kappelle L.J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33 (2002) 2115-2122
11. Nagel T., Resnick N., Atkinson W.J., et al. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 94 (1994) 885-891
12. Huang J., Choudhri T.F., Winfree C.J., et al. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke 31 (2000) 3047-3053
13. Sure U., Battenberg E., Dempfle A., et al. Hypoxia-inducible factor and vascular endothelial growth factor are expressed more frequently in embolized than in nonembolized cerebral arteriovenous malformations. Neurosurgery 55 (2004) 663-669 discussion 669-70
14. Thorpe P.E., Chaplin D.J., and Blakey D.C. The first international conference on vascular targeting: meeting overview. Cancer Res 63 (2003) 1144-1147
15. Baguley B.C. Antivascular therapy of cancer: DMXAA. Lancet Oncol 4 (2003) 141-148
16. Brekken R.A., and Thorpe P.E. Vascular endothelial growth factor and vascular targeting of solid tumors. Anticancer Res 21 (2001) 4221-4229